Le génome humain minimal : un objectif plus précieux que de copier la nature

Only 2% of the human genome codes for genes. The remaining 98% is a sprawling mix of regulatory sequences, structural elements, and functional dark matter we barely understand.

A synthetic human genome project announced in 2016 aimed to slash the cost of engineering large genomes by 1,000-fold within a decade and produce an “ultrasafe” cell line resistant to viral infection. It never got off the ground — the tech wasn't ready, funding dried up, and the project remained a stack of pilot proposals.

The Original Plan Had the Wrong Target

That ultrasafe cell line was arguably of limited scientific value. Broad virus resistance requires rewriting the genetic code across thousands of sites, leaning heavily on known redundancy rather than uncovering new biology. Targeted strategies — blocking viral entry or modifying a smaller set of genes — can often do the job without a whole-genome rewrite.

A more transformative goal: define the minimal human genome. Strip it down to the smallest set of genetic elements required for a cell to function. Every time you remove a sequence, you learn whether it was needed. That’s how you map essential biology.

We’ve Seen This Work Before

Researchers reduced the genome of Mycoplasma mycoides from 901 genes to 473 and discovered a class of “quasi-essential” genes — dispensable in isolation but necessary for healthy growth (Hutchison et al., Science 351, 2016). A human minimal genome would do the same at scale.

Three concrete benefits: (1) It would transform our understanding of which genetic combinations are sufficient for a cell to function. (2) Minimal genomes reduce risks in biomedicine — less genetic baggage means fewer unwanted gene expressions, a direct win for CAR T-cell therapies. (3) Smaller genomes are cheaper and easier to synthesize, lowering the barrier for both the initial project and everything that follows.

Tech Is Finally Ready — And Funders Are Moving

DNA synthesis and assembly methods have improved enough to reliably produce long genomic sequences. Artificial-intelligence models can now predict how DNA changes affect cell biology. UK researchers launched a £10-million (US$13-million) project in 2025 aiming to build the first fully synthetic human chromosome.

But governance needs to catch up. The same methods that write synthetic human genomes could write pathogen genomes. Proactive oversight — modeled on the 1975 Asilomar conference on recombinant DNA and the Human Genome Project’s ELSI program — is essential. An oversight committee with scientists, ethicists, and the public, empowered to stop funding, should guide what gets built.

Ten years from now, I want a first-year graduate student to walk into a meeting where the debate isn't whether we can build a minimal human genome — but what we'll learn when we do.

Source: Why a synthetic human genome is still worth building
Domain: nature.com